RNS Number : 3903W
Legal & General UCITS ETF PLC
17 August 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
17/08/2020 |
IE00BFXR5Q31 |
13147267 |
USD |
168298644.02 |
12.801 |
| L&G UK Equity UCITS ETF |
17/08/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
10911850.83 |
9.093 |
| L&G Global Equity UCITS ETF |
17/08/2020 |
IE00BFXR5S54 |
2900000 |
USD |
35449955.03 |
12.224 |
| L&G Japan Equity UCITS ETF |
17/08/2020 |
IE00BFXR5T61 |
11185000 |
USD |
122729362.07 |
10.973 |
| L&G Europe ex UK Equity UCITS ETF |
17/08/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
103017949.06 |
11.005 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
17/08/2020 |
IE00BFXR5W90 |
5281427 |
USD |
57627327.32 |
10.911 |
| L&G Clean Water UCITS ETF |
17/08/2020 |
IE00BK5BC891 |
1650000 |
USD |
19007834.98 |
11.520 |
| L&G Artificial Intelligence UCITS ETF |
17/08/2020 |
IE00BK5BCD43 |
7946000 |
USD |
110966619.50 |
13.965 |
| L&G Healthcare Innovation UCITS ETF |
17/08/2020 |
IE00BK5BC677 |
3100000 |
USD |
43612427.21 |
14.069 |
| L&G Pharma Breakthrough UCITS ETF |
17/08/2020 |
IE00BF0H7608 |
2000000 |
USD |
25401973.63 |
12.701 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
17/08/2020 |
IE00BKLTRN76 |
9600000 |
EUR |
99820754.18 |
10.398 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
17/08/2020 |
IE00BKLWY790 |
57800000 |
USD |
667676543.53 |
11.551 |
| L&G Battery Value-Chain UCITS ETF |
17/08/2020 |
IE00BF0M2Z96 |
14450000 |
USD |
158270620.94 |
10.953 |
| L&G Ecommerce Logistics UCITS ETF |
17/08/2020 |
IE00BF0M6N54 |
9600000 |
USD |
116778955.76 |
12.164 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
17/08/2020 |
IE00BMW3QX54 |
46430616 |
USD |
884113555.51 |
19.042 |
| L&G Cyber Security UCITS ETF |
17/08/2020 |
IE00BYPLS672 |
84356776 |
USD |
1672350372.01 |
19.825 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVDZGMRZNFGGZZ
